Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy

Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy

Background and aimSepsis is a syndromic response to infection and is associated with high mortality, thus imposing a significant global burden of disease. Although low-molecular-weight heparin (LMWH) has been recommended to prevent venous thromboembolism, its anticoagulant and anti-inflammatory effe...

Full description

Bibliographic Details
Main Authors: Ze Zhang, Taotao Yan, Danfeng Ren, Jingwen Zhou, Liangru Liu, Juan Li, Shan Fu, Tianzhi Ni, Weicheng Xu, Yuan Yang, Tianyan Chen, Yingli He, Yingren Zhao, Jinfeng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Medicine
Subjects:
low-molecular-weight heparin
disseminated intravascular coagulation
sepsis
mortality
propensity score
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1157775/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1157775/full

Similar Items